| CRISPR corrects rare childhood diseaseRosa Bacchetta and colleagues from Stanford University have demonstrated a smart CRISPR gene editing strategy as a feasible therapy for a rare, life-threatening paediatric autoimmune disease. Read more about the approach to treat IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome by inserting the FOXP3 gene at exactly the right spot in the genome in our interview with Bacchetta. | |